The third cluster (blue, 124 items) centers on inflammation-related pathways and specific pathological conditions, incorporating both molecular mediators (Nrf2, NLRP3, HMGB1) and disease states (atherosclerosis, ulcerative colitis, liver diseases). This evidence concerns the gene HMGB1 and ulcerative colitis.